{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:27:33Z","timestamp":1777015653026,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jsat.2021.108328","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T03:48:01Z","timestamp":1613015281000},"page":"108328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Use of an electronic pillbox to increase number of methadone take-home doses during the COVID-19 pandemic"],"prefix":"10.1016","volume":"126","author":[{"given":"Michael","family":"Kidorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Brooner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Peirce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108328_bb0005","series-title":"Using community pharmacies to bring methadone treatment to scale for opioid use disorder: Process and progress. Presented at the Annual American Psychopathological Association Conference, New York City, NY, March 5, 2020","author":"Brooner","year":"2020"},{"key":"10.1016\/j.jsat.2021.108328_bb0010","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: What the United States can learn from the global effort to treatment opioid addiction","volume":"34","author":"Calcaterra","year":"2019","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108328_bb0015","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jsat.2021.108328_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108197","article-title":"Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic","author":"Dunn","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108328_bb0025","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","volume":"8","author":"Gowing","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2021.108328_bb0030","doi-asserted-by":"crossref","first-page":"107115","DOI":"10.1016\/j.drugalcdep.2019.06.017","article-title":"Fentanyl exposure and preferences among individuals starting opioid use disorder","volume":"204","author":"Gryczynski","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108328_bb0035","first-page":"1","article-title":"Drug most frequently involved in drug overdose deaths: United States, 2011-2016","volume":"67","author":"Hedegaard","year":"2018","journal-title":"National Vital Statistics Report"},{"key":"10.1016\/j.jsat.2021.108328_bb0040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.15585\/mmwr.mm6526a2","article-title":"Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths - United States, 2002-2014","volume":"65","author":"Jones","year":"2016","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2021.108328_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108328_bb0050","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 U.S. states","volume":"322","author":"Joudry","year":"2019","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2021.108328_bb0055","article-title":"Methadone for opioid use disorder \u2013 Decades of effectiveness but still miles away in the U.S","author":"Joudry","year":"2020","journal-title":"Journal of the American Medical Association Psychiatry"},{"key":"10.1016\/j.jsat.2021.108328_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/00952991003736371","article-title":"The role of patient satisfaction in methadone treatment","volume":"36","author":"Kelly","year":"2010","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108328_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1521\/pedi_2019_33_429","article-title":"Impact of personality disorder on the treatment of psychiatric disorders in people receiving methadone-assisted treatment","volume":"28","author":"Kidorf","year":"2019","journal-title":"Journal of Personality Disorders"},{"key":"10.1016\/j.jsat.2021.108328_bb0070","article-title":"Comparison of driving times to opioid treatment programs and pharmacies in the U.S","author":"Kleinman","year":"2020","journal-title":"Journal of the American Medical Association Psychiatry"},{"key":"10.1016\/j.jsat.2021.108328_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2018.10.007","article-title":"Fentanyl exposure among patients seeking opioid treatment","volume":"96","author":"Ochalek","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108328_bb0085","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.jsat.2021.108328_bb0090","unstructured":"Title 42, part 8. Medication assisted treatment for opioid use disorder. Code of Federal Regulations."},{"key":"10.1016\/j.jsat.2021.108328_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.36469\/jheor.2018.9787","article-title":"Identifying priority areas for increasing the supply of medication-assisted treatments for opioid use disorder: A geospatial approach","volume":"16","author":"Topmiller","year":"2018","journal-title":"Journal of Health and Economics Outcome Research"},{"key":"10.1016\/j.jsat.2021.108328_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/M20-1212","article-title":"Collison of the COVID-19 and addiction epidemics","volume":"173","author":"Volkow","year":"2020","journal-title":"Annals of Internal Medicine"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:15Z","timestamp":1760039595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":19,"alternative-id":["S0740547221000544"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108328","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of an electronic pillbox to increase number of methadone take-home doses during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108328"}}